Objective: To find out the relation between endothelial microparticles (EMPs), pulmonary arterial stiffness and thickness of pulmonary artery intima media to determine the prognosis of Eisenmenger syndrome and their correlation with echocardiographic and hemodynamic parameters
Pulmonary arterial hypertension is a deadly disease characterized by elevated pulmonary arterial pre...
Pulmonary hypertension (PH) is a common abnormality, most often associated with various cardiopulmon...
Biomarkers are attractive non-invasive tools for estimating and monitoring pulmonary arterial hypert...
Objective: To find out the relation between endothelial microparticles (EMPs), pulmonary arterial st...
Endothelial microparticles (EMPs) are markers of endothelial injury and activation. The role of EMPs...
Background: The aim of current study is to investigate echocardiographic pulmonary artery wall thick...
Vasoreactivity testing is recommended in the management of pulmonary arterial hypertension (PAH), bu...
Objective Eisenmenger syndrome (ES) is a severe form of pulmonary hypertension in adults with congen...
<p><b>A)</b> Percentage of endothelial microparticles (Ec-MPs) as defined by CD144<sup>+</sup> micro...
Pulmonary arterial hypertension: correlation between severity of pathology and new markers of endoth...
ObjectivesThis study sought to determine what factors are associated with pulmonary artery thrombi i...
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associate...
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associate...
ABSTRACT: The respective abundance of circulating endothelial cells and endothelial progenitor cells...
Pulmonary arterial hypertension (PAH), associated with congenital heart disease (CHD), usually resul...
Pulmonary arterial hypertension is a deadly disease characterized by elevated pulmonary arterial pre...
Pulmonary hypertension (PH) is a common abnormality, most often associated with various cardiopulmon...
Biomarkers are attractive non-invasive tools for estimating and monitoring pulmonary arterial hypert...
Objective: To find out the relation between endothelial microparticles (EMPs), pulmonary arterial st...
Endothelial microparticles (EMPs) are markers of endothelial injury and activation. The role of EMPs...
Background: The aim of current study is to investigate echocardiographic pulmonary artery wall thick...
Vasoreactivity testing is recommended in the management of pulmonary arterial hypertension (PAH), bu...
Objective Eisenmenger syndrome (ES) is a severe form of pulmonary hypertension in adults with congen...
<p><b>A)</b> Percentage of endothelial microparticles (Ec-MPs) as defined by CD144<sup>+</sup> micro...
Pulmonary arterial hypertension: correlation between severity of pathology and new markers of endoth...
ObjectivesThis study sought to determine what factors are associated with pulmonary artery thrombi i...
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associate...
Eisenmenger syndrome (ES), the most advanced form of pulmonary arterial hypertension (PAH) associate...
ABSTRACT: The respective abundance of circulating endothelial cells and endothelial progenitor cells...
Pulmonary arterial hypertension (PAH), associated with congenital heart disease (CHD), usually resul...
Pulmonary arterial hypertension is a deadly disease characterized by elevated pulmonary arterial pre...
Pulmonary hypertension (PH) is a common abnormality, most often associated with various cardiopulmon...
Biomarkers are attractive non-invasive tools for estimating and monitoring pulmonary arterial hypert...
DOI
Add to ORKG